Success Metrics

Clinical Success Rate
100.0%

Based on 9 completed trials

Completion Rate
100%(9/9)
Active Trials
11(39%)
Results Posted
22%(2 trials)

Phase Distribution

Ph early_phase_1
1
4%
Ph phase_2
2
7%
Ph phase_3
10
36%
Ph phase_1
4
14%
Ph phase_4
11
39%

Phase Distribution

5

Early Stage

2

Mid Stage

21

Late Stage

Phase Distribution28 total trials
Early Phase 1First-in-human
1(3.6%)
Phase 1Safety & dosage
4(14.3%)
Phase 2Efficacy & side effects
2(7.1%)
Phase 3Large-scale testing
10(35.7%)
Phase 4Post-market surveillance
11(39.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

9 of 9 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

11

trials recruiting

Total Trials

28

all time

Status Distribution
Active(19)
Completed(9)

Detailed Status

Completed9
Recruiting9
Not yet recruiting6
Enrolling by invitation2
Active, not recruiting2

Development Timeline

Analytics

Development Status

Total Trials
28
Active
11
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (3.6%)
Phase 14 (14.3%)
Phase 22 (7.1%)
Phase 310 (35.7%)
Phase 411 (39.3%)

Trials by Status

not_yet_recruiting621%
completed932%
recruiting932%
enrolling_by_invitation27%
active_not_recruiting27%

Recent Activity

Clinical Trials (28)

Showing 20 of 28 trialsScroll for more
NCT07355166Phase 4

Suzetrigine Versus Usual-care Opioids for Postop Pain in Sports

Not Yet Recruiting
NCT07226700Phase 3

Suzetrigine in Total Hip Arthroplasty

Recruiting
NCT07525219Phase 3

Suzetrigine Frame Trial Comparing Suzetrigine and Acetaminophen

Recruiting
NCT07231419Phase 3

Evaluation of Efficacy and Safety of Suzetrigine (SUZ) for Pain Associated With Diabetic Peripheral Neuropathy

Recruiting
NCT07672015Phase 4

Precision Pain Management - A Randomized Clinical Trial Assessing the Efficacy of Suzetrigine on Postoperative Analgesia Among Surgical Patients at Higher Risk for Persistent Postoperative Opioid Use (POU)

Recruiting
NCT07570069Phase 1

Effects of Efavirenz on the Pharmacokinetics of Suzetrigine in Healthy Participants

Active Not Recruiting
NCT07511400Early Phase 1

The Role of NaV1.8 in Human Pain Models

Completed
NCT07654296Phase 3

Assessing Suzetrigine for Pain Reduction Following Ureteroscopic Surgery

Not Yet Recruiting
NCT06628908Phase 3

Evaluation of Efficacy and Safety of Suzetrigine for Pain Associated With Diabetic Peripheral Neuropathy

Recruiting
NCT07624526Phase 4

Role of Suzetrigine as a Part of a Multimodal Regimen to Reduce Pain and Opioid Use After Total Knee Arthroplasty

Not Yet Recruiting
NCT07600697Phase 4

Suzetrigine for Opioid-Sparing Postoperative Analgesia Following Transvaginal Pelvic Reconstructive Surgery

Not Yet Recruiting
NCT06774625Phase 2

This is a Study Evaluating the Efficacy and Safety of LTG-001 for Acute Pain After Surgical Removal of Impacted Third Molars

Completed
NCT06696443Phase 3

Evaluation of the Long-term Safety and Effectiveness of Suzetrigine (SUZ) in Participants With Painful Diabetic Peripheral Neuropathy (DPN)

Active Not Recruiting
NCT07539623Phase 3

Suzetrigine-enhanced MultimOdal Opioid-sparing THerapy in Cardiac and Bariatric SURGery

Recruiting
NCT07378865Phase 1

Evaluation of the Excretion of Suzetrigine Into Breast Milk in Healthy Lactating Female Participants

Recruiting
NCT07538570Phase 4

Evaluation of Pain Treatment After Total Knee Arthroplasty

Recruiting
NCT07575230Phase 4

Suzetrigine vs Norco-postoperative Mohs Pain

Enrolling By Invitation
NCT07257133Phase 4

A Study Of Opioid Avoidance In Surgery Through Integrating Suzetrigine

Completed
NCT07463430Phase 4

Suzetrigine for Non-Mastectomy Breast Surgery

Enrolling By Invitation
NCT07548385Phase 3

Suzetrigine for Treatment and Reduction of Intense Discomfort After knEe Replacement PAIN

Recruiting

Drug Details

Intervention Type
DRUG
Total Trials
28